Walleye Capital’s Organogenesis Holdings ORGO Stock Holding History

Walleye Capital’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,232	Closed	-$44.8K	–	4955
2025 Q2	$44.8K	Buy	+12,232	New	+$45.6K	﹤0.01%	4070
2023 Q3	–	Sell	-30,123	Closed	-$100K	–	5199
2023 Q2	$100K	Sell	30,123 -21,711	-42%	-$64.2K	﹤0.01%	3432
2023 Q1	$110K	Buy	51,834 +31,747	+158%	+$78.4K	﹤0.01%	2873
2022 Q4	$54K	Buy	+20,087	New	+$58.6K	﹤0.01%	2509
2022 Q3	–	Sell	-15,355	Closed	-$75K	–	3449
2022 Q2	$75K	Buy	+15,355	New	+$94.5K	﹤0.01%	1789
2021 Q2	–	Sell	-55,437	Closed	-$1.01K	–	1465
2021 Q1	$1.01K	Sell	55,437 -53,397	-49%	-$723K	0.06%	296
2020 Q4	$820	Buy	+108,834	New	+$517K	0.05%	339

Other funds holding ORGO

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Capital's ORGO Position: Q3 2025 in Review

Walleye Capital sold out of Organogenesis Holdings (ORGO) in Q3 2025, closing a stake of 12,232 shares — an estimated $44.8K sold.

Walleye Capital first reported a position in ORGO in Q4 2020 and held it in 7 quarters. The position peaked at $110K in Q1 2023. 121 funds tracked by Wall St. Rank hold ORGO as of Q3 2025.

Walleye Capital reported no remaining Organogenesis Holdings position as of Q3 2025 after selling out during the quarter.
Walleye Capital sold 12,232 Organogenesis Holdings shares in Q3 2025, an estimated $44.8K.
Walleye Capital first reported a position in Organogenesis Holdings in Q4 2020 and held it in 7 quarters.
Walleye Capital's Organogenesis Holdings position peaked at $110K in Q1 2023.
121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2025.

Based on Walleye Capital's 13F filing for Q3 2025, filed 14 Nov 2025.